Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Epitope
100%
T Cells
100%
Lymphoma
100%
T Cell Response
100%
Idiotype
100%
Immunodominant Epitopes
28%
Antigenic Epitope
28%
Vaccinated Individuals
28%
Tumor
14%
Clinically Significant
14%
Inflammatory Cytokines
14%
Autologous Tumors
14%
CD4+
14%
T Cell Lines
14%
Adoptive Immunotherapy
14%
Synthetic Peptides
14%
Lymphoma Patients
14%
Tumor Antigen
14%
CD8+ T Cells
14%
Vaccine Strategy
14%
Somatic Hypermutation
14%
Hypervariable
14%
Amino-terminus
14%
Active Immunization
14%
Peptide Vaccine
14%
Novel Peptide
14%
Tumor Antigen-specific T Cell
14%
T Cell Immunity
14%
B-cell Malignancies
14%
Molecular Remission
14%
Malignant B Cells
14%
Ig Receptor
14%
Framework Regions
14%
Autologous T Cells
14%
Specific T Cell Response
14%
T-cell Epitope
14%
Ig Heavy Chain
14%
Immunology and Microbiology
Epitope
100%
T Cell
100%
Idiotype
100%
Lymphoma Vaccine
100%
B Cell
28%
Tumor Antigen
28%
Cell Line
14%
T-Helper Cell
14%
Amino Terminal Sequence
14%
Intravenous Immunoglobulin
14%
Adoptive Immunotherapy
14%
Adoptive Immunity
14%
Proinflammatory Cytokine
14%
Cytotoxic T-Cell
14%
Immunoglobulin Heavy Chain
14%
Somatic Hypermutation
14%
Active Immunotherapy
14%
Peptide Vaccine
14%
Framework Region
14%
Peptides
14%